Skip to main content

DISEÑO ESTRUCTURAL DE GLICOPEPTIDOS DE TIPO MUCINA QUE INCORPORAN MIMETICOS DEL ANTIGENO TN PARA DESARROLLAR BIOMARCADORES Y VACUNAS CONTRA EL CANCER

CTQ2015-67727-R

•
Funding agency name Ministerio de Economía y Competitividad
Funding agency acronym MINECO
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2015
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Management unit Dirección General de Investigación Científica y Técnica
Beneficiary centre UNIVERSIDAD DE LA RIOJA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Publication Artículo científico (JournalArticle)

Chemo- and Regioselective Lysine Modification on Native Proteins

  • Matos, Maria João Correia Pinto Carvalho de
  • Oliveira, Bruno L.
  • Martínez Saéz, Nuria
  • Guerreiro, Ana
  • Cal, Pedro M.S.D.
  • Bertoldo, Jean Borges
  • Maneiro Rey, María
  • Perkins, Elizabeth
  • Howard, Julie A.
  • Deery, Michael J.
  • Chalker, Justin M.
  • Corzana, Francisco
  • Jiménez Osés, Gonzalo
  • Bernardes, Gonçalo J.L.
Site-selective chemical conjugation of synthetic molecules to proteins expands their functional and therapeutic capacity. Current protein modification methods, based on synthetic and biochemical technologies, can achieve site selectivity, but these techniques often require extensive sequence engineering or are restricted to the N- or C-terminus. Here we show the computer-assisted design of sulfonyl acrylate reagents for the modification of a single lysine residue on native protein sequences. This feature of the designed sulfonyl acrylates, together with the innate and subtle reactivity differences conferred by the unique local microenvironment surrounding each lysine, contribute to the observed regioselectivity of the reaction. Moreover, this site selectivity was predicted computationally, where the lysine with the lowest pKa was the kinetically favored residue at slightly basic pH. Chemoselectivity was also observed as the reagent reacted preferentially at lysine, even in those cases when other nucleophilic residues such as cysteine were present. The reaction is fast and proceeds using a single molar equivalent of the sulfonyl acrylate reagent under biocompatible conditions (37 °C, pH 8.0). This technology was demonstrated by the quantitative and irreversible modification of five different proteins including the clinically used therapeutic antibody Trastuzumab without prior sequence engineering. Importantly, their native secondary structure and functionality is retained after the modification. This regioselective lysine modification method allows for further bioconjugation through aza-Michael addition to the acrylate electrophile that is generated by spontaneous elimination of methanesulfinic acid upon lysine labeling. We showed that a protein–antibody conjugate bearing a site-specifically installed fluorophore at lysine could be used for selective imaging of apoptotic cells and detection of Her2+ cells, respectively. This simple, robust method does not require genetic engineering and may be generally used for accessing diverse, well-defined protein conjugates for basic biology and therapeutic studies
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The use of fluoroproline in MUC1 antigen enables efficient detection of antibodies in patients with prostate cancer

  • Somovilla, Víctor J.
  • Bermejo, Iris A.
  • Albuquerque, Inês S.
  • Martínez-Sáez, Nuria
  • Castro-López, Jorge
  • García-Martín, Fayna
  • Compañón, Ismael
  • Hinou, Hiroshi
  • Nishimura, Shin-Ichiro
  • Jiménez-Barbero, Jesús
  • Asensio, Juan Luis
  • Avenoza, Alberto
  • Busto, Jesús H.
  • Hurtado-Guerrero, Ramón
  • Peregrina, Jesús M.
  • Bernardes, Gonçalo J.L.
  • Corzana, Francisco
A structure-based design of a new generation of tumor-associated glycopeptides with improved affinity against two anti-MUC1 antibodies is described. These unique antigens feature a fluorinated proline residue, such as a (4S)-4-fluoro-l-proline or 4,4-difluoro-l-proline, at the most immunogenic domain. Binding assays using biolayer interferometry reveal 3-fold to 10-fold affinity improvement with respect to the natural (glyco)peptides. According to X-ray crystallography and MD simulations, the fluorinated residues stabilize the antigen-antibody complex by enhancing key CH/π interactions. Interestingly, a notable improvement in detection of cancer-associated anti-MUC1 antibodies from serum of patients with prostate cancer is achieved with the non-natural antigens, which proves that these derivatives can be considered better diagnostic tools than the natural antigen for prostate cancer., We thank the Ministerio de Economía y Competitividad (projects CTQ2015-67727-R, UNLR13-4E-1931, CTQ2013-44367-C2-2-P, CTQ2015-64597-C2-1P, and BFU2016-75633-P). I.A.B. thanks the Asociación Española Contra el Cancer en La Rioja for a grant. I.S.A. and G.J.L.B. thank FCT Portugal (Ph.D. studentship and FCT Investigator, respectively) and EPSRC. G.J.L.B. holds a Royal Society URF and an ERC StG (TagIt). F.C. and G.J.L.B thank the EU (Marie-Sklodowska Curie ITN, Protein Conjugates). R.H-G. thanks Agencia Aragonesa para la Investigación y Desarrollo (ARAID) and the Diputación General de Aragón (DGA, B89) for financial support. The research leading to these results has also received funding from the FP7 (2007-2013) under BioStruct-X (grant agreement no. 283570 and BIOSTRUCTX_5186). We thank synchrotron radiation source DIAMOND (Oxford) and beamline I04 (number of experiment mx10121-19). The Hokkaido University group acknowledges JSPS KAKENHI grant no. 25220206 and JSPS Wakate B KAKENHI grant no. 24710242. We also thank CESGA (Santiago de Compostela) for computer support., Peer reviewed, Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Tn Antigen Mimics Based on sp2-Iminosugars with Affinity for an anti-MUC1 Antibody

  • Fernández, E. M. S.
  • Navo, C. D.
  • Martínez-Sáez, N.
  • Gonçalves-Pereira, Rita
  • Somovilla, Víctor J.
  • Avenoza, Alberto
  • Busto, Jesús H.
  • Bernardes, G. J. L.
  • Jiménez-Osés, Gonzalo
  • Corzana, Francisco
  • García Fernández, José Manuel
  • Mellet, C. O.
  • Peregrina, Jesús M.
The first examples of amino acid (Ser/Thr)-sp-iminosugar glycomimetic conjugates featuring an α-O-linked pseudoanomeric linkage are reported. The key synthetic step involves the completely diastereoselective α-glycosylation of Ser/Thr due to strong stereoelectronic and conformational bias imposed by the bicyclic sp-iminosugar scaffold. Mucin-related glycopeptides incorporating these motifs were recognized by the monoclonal antibody (mAb) scFv-SM3, with activities depending on both the hydroxylation pattern (Glc/Gal/GlcNAc/GalNAc) of the sp-iminosugar and the peptide aglycone structure (Ser/Thr)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Structure-Based Design of Potent Tumor-Associated Antigens: Modulation of Peptide Presentation by Single-Atom O/S or O/Se Substitutions at the Glycosidic Linkage

  • Companión, I.
  • Guerreiro, A.
  • Mangini, V.
  • Castro-López, Jorge
  • Escudero-Casao, M.
  • Avenoza, Alberto
  • Busto, J. H.
  • Castillón, S.
  • Jiménez-Barbero, Jesús
  • Asensio, Juan Luis
  • Jiménez-Osés, Gonzalo
  • Boutureira, O.
  • Peregrina, Jesús M.
  • Hurtado-Guerrero, R.
  • Fiammengo, R.
  • Bernardes, G. J. L.
  • Corzana, Francisco
GalNAc-glycopeptides derived from mucin MUC1 are an important class of tumor-associated antigens. α-O-glycosylation forces the peptide to adopt an extended conformation in solution, which is far from the structure observed in complexes with a model anti-MUC1 antibody. Herein, we propose a new strategy for designing potent antigen mimics based on modulating peptide/carbohydrate interactions by means of O â†' S/Se replacement at the glycosidic linkage. These minimal chemical modifications bring about two key structural changes to the glycopeptide. They increase the carbohydrate-peptide distance and change the orientation and dynamics of the glycosidic linkage. As a result, the peptide acquires a preorganized and optimal structure suited for antibody binding. Accordingly, these new glycopeptides display improved binding toward a representative anti-MUC1 antibody relative to the native antigens. To prove the potential of these glycopeptides as tumor-associated MUC1 antigen mimics, the derivative bearing the S-glycosidic linkage was conjugated to gold nanoparticles and tested as an immunogenic formulation in mice without any adjuvant, which resulted in a significant humoral immune response. Importantly, the mice antisera recognize cancer cells in biopsies of breast cancer patients with high selectivity. This finding demonstrates that the antibodies elicited against the mimetic antigen indeed recognize the naturally occurring antigen in its physiological context. Clinically, the exploitation of tumor-associated antigen mimics may contribute to the development of cancer vaccines and to the improvement of cancer diagnosis based on anti-MUC1 antibodies. The methodology presented here is of general interest for applications because it may be extended to modulate the affinity of biologically relevant glycopeptides toward their receptors., We thank the Ministerio de Economıá y Competitividad (projects CTQ2015-67727-R, CTQ2013-44367-C2-2-P, CTQ2015-64597-C2-1P, CTQ2017-89750-R, CTQ2017- 90088-R, CTQ2015-70524-R, and BFU2016-75633-P) and the Italian Ministry of Education, University and Research (MIUR) (PRIN 2015 contract no. 2015RNWJAM). I.C. thanks Universidad de La Rioja for an FPI grant. A.G. and G.J.L.B. thank FCT Portugal (Ph.D. studentship, SFRH/BD/ 115932/2016 and FCT Investigator IF/00624/2015, respectively). G.J.L.B. holds a Royal Society URF (UF110046 and URF\R\180019) and an ERC StG (TagIt, GA no. 676832). F.C. and G.J.L.B. thank the EU (Marie-Sklodowska Curie ITN, Protein Conjugates, GA no. 675007). O.B. and G.J.-O. are Ramón y Cajal Fellows (RYC-2015-17705 and RYC-2013- 14706, respectively). R.H-G. thanks Agencia Aragonesa para la Investigación y Desarrollo (ARAID) and the Diputación General de Aragón (DGA, E34_R17) for financial support. The research that led to these results also attracted funding from the FP7 (2007-2013) under BioStruct-X (grant agreement no. 283570 and BIOSTRUCTX_5186). We also thank the ALBA synchrotron radiation source, in particular, the beamline XALOC facility. We thank Emanuele Papini and Regina Tavano (University of Padua, Italy) for insightful discussions about the immunogenicity of glycopeptidefunctionalized AuNPs and Vito Maggi and Valentina Rosato (IIT-Lecce) for expert technical assistance. Computational resources of CESGA (Santiago de Compostela) and BERONIA (Universidad de La Rioja) were used in this work. The authors thank Vikki Cantrill for her help with the preparation and editing of this article., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Water Sculpts the Distinctive Shapes and Dynamics of the Tumor-Associated Carbohydrate Tn Antigens: Implications for Their Molecular Recognition

  • Bermejo, I. A.
  • Usabiaga, Imanol
  • Compañón, Ismael
  • Castro-López, Jorge
  • Insausti, Aran
  • Fernández, José A.
  • Avenoza, Alberto
  • Busto, Jesús H.
  • Jiménez-Barbero, Jesús
  • Asensio, Juan Luis
  • Peregrina, Jesús M.
  • Jiménez-Osés, Gonzalo
  • Hurtado-Guerrero, R.
  • Cocinero, Emilio J.
  • Corzana, Francisco
The tumor-associated carbohydrate Tn antigens include two variants, αGalNAc-O-Thr and αGalNAc-O-Ser. In solution, they exhibit dissimilar shapes and dynamics and bind differently to the same protein receptor. Here, we demonstrate experimentally and theoretically that their conformational preferences in the gas phase are highly similar, revealing the essential role of water. We propose that water molecules prompt the rotation around the glycosidic linkage in the threonine derivative, shielding its hydrophobic methyl group and allowing an optimal solvation of the polar region of the antigen. The unusual arrangement of αGalNAc-O-Thr features a water molecule bound into a >pocket> between the sugar and the threonine. This mechanism is supported by trapping, for the first time, such localized water in the crystal structures of an antibody bound to two glycopeptides that comprise fluorinated Tn antigens in their structure. According to several reported X-ray structures, installing oxygenated amino acids in specific regions of the receptor capable of displacing the bridging water molecule to the bulk-solvent may facilitate the molecular recognition of the Tn antigen with threonine. Overall, our data also explain how water fine-tunes the 3D structure features of similar molecules, which in turn are behind their distinct biological activities., We thank MINECO (projects CTQ2015-67727-R and UNLR13-4E-1931 to F.C. and J.M.P; CTQ2013-44367-C2-2-P and BFU2016-75633-P to R.H.-G.; CTQ2015-64597-C2-1P to J.J.-B.; CTQ2015-70524-R and RYC-2013-14706 to G.J.O; SEV-2016-0644 to CIC bioGUNE; CTQ2017-89150-R to E.J.C.; and CTQ2015-68148-C2-1-P to J.A.F.). F.C. thanks the EU (Marie-Sklodowska Curie ITN, ProteinConjugates). J.A.F. and E.J.C. thank UPV/EHU (UFI11/23 and PPG17/10) for financial support. I.A.B. thanks the Asociación Española Contra el Cancer en La Rioja for a grant. I.C. thanks Universidad de La Rioja for the FPI grant. R.H-G. thanks Agencia Aragonesa para la Investigación y Desarrollo (ARAID) and the Diputación General de Aragón (DGA, group number E34_R17) for financial support. The research leading to these results has also received funding from the FP7 (2007-2013) under BioStruct-X (grant agreement no. 283570 and BIOSTRUCTX_ 5186). We thank synchrotron radiation source ALBA (Barcelona) and beamline XALOC. Computational resources of CESGA, Universidad de La Rioja (BERONIA) and UPV/EHU (SGIker and I2Basque) were used in this work. We thank Prof. J. P. Simons (Oxford University) for valuable comments and scientific discussions., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Dynamic acetylation of phosphoenolpyruvate carboxykinase toggles enzyme activity between gluconeogenic and anaplerotic reactions

  • Latorre-Muro, Pedro
  • Baeza, Josue
  • Armstrong, Eric A.
  • Hurtado-Guerrero, Ramón
  • Corzana, Francisco
  • Wu, Lindsay E.
  • Sinclair, David A.
  • López-Buesa, P.
  • Carrodeguas, José A.
  • Denu, John M.
24 pags, 6 figs. -- Supplemental Information includes five figures, five tables, and four videos and can be found with this article online at https://doi.org/10.1016/j.molcel.2018.07.031., Cytosolic phosphoenolpyruvate carboxykinase (PCK1) is considered a gluconeogenic enzyme; however, its metabolic functions and regulatory mechanisms beyond gluconeogenesis are poorly understood. Here, we describe that dynamic acetylation of PCK1 interconverts the enzyme between gluconeogenic and anaplerotic activities. Under high glucose, p300-dependent hyperacetylation of PCK1 did not lead to protein degradation but instead increased the ability of PCK1 to perform the anaplerotic reaction, converting phosphoenolpyruvate to oxaloacetate. Lys91 acetylation destabilizes the active site of PCK1 and favors the reverse reaction. At low energy input, we demonstrate that SIRT1 deacetylates PCK1 and fully restores the gluconeogenic ability of PCK1. Additionally, we found that GSK3β-mediated phosphorylation of PCK1 decreases acetylation and increases ubiquitination. Biochemical evidence suggests that serine phosphorylation adjacent to Lys91 stimulates SIRT1-dependent deacetylation of PCK1. This work reveals an unexpected capacity of hyperacetylated PCK1 to promote anaplerotic activity, and the intersection of post-translational control of PCK1 involving acetylation, phosphorylation, and ubiquitination., Recombinant SIRT1 and SIRT2 were kindly supplied by Beatriz Camacho (UW Madison) and Mark A. Klein (UW Madison), respectively. Jin-Hee Lee (UW Madison) provided the X. laevis Histone H4. Susana Llanos (CNIO, Madrid, Spain) provided the human p300-HA clone. We thank Jing Fan (UW Madison) for discussions on metabolite flux and tracing experiments. We thank S.V. Medaris (UW Madison) for providing graphical support for Rgure 7. P.L.-M. was funded by a predoctoral fellowship from the "la Caixa" Foundation and received financial support from the Universidad de Zaragoza, Fundacion Bancaria lbercaja y Fundacion CAI (CM 1/16) during his stay at the UW Madison. This work has been funded by grants DK100263 and AG028730 (to D.A.S.). We acknowledge grants AGL2015-66177 (to P.L.-B. and J.A.C.) and CTQ2015-67727-R (to F.C.) from the Ministerio de Economia. Industria y Competitividad and UZ 2014-CIE-03 (to P.L-B.) and UZ-2015-B10-01 (to J.A.C.) from the University of Zaragoza. We thank ARAID and MEC (CTQ2013-44367-C2-2-P and BFU2016-75633-P to R.H.-G.). J.M.D acknowledges NIH grant GM065386., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The Use of Fluoroproline in MUC1 Antigen Enables Efficient Detection of Antibodies in Patients with Prostate Cancer

  • Somovilla, V.J.
  • Bermejo, I.A.
  • Albuquerque, I.S.
  • Martínez-Sáez, N.
  • Castro-López, J.
  • García-Martín, F.
  • Compañón, I.
  • Hinou, H.
  • Nishimura, S.-I.
  • Jiménez-Barbero, J.
  • Asensio, J.L.
  • Avenoza, A.
  • Busto, J.H.
  • Hurtado-Guerrero, R.
  • Peregrina, J.M.
  • Bernardes, G.J.L.
  • Corzana, F.
A structure-based design of a new generation of tumor-associated glycopeptides with improved affinity against two anti-MUC1 antibodies is described. These unique antigens feature a fluorinated proline residue, such as a (4S)-4-fluoro-l-proline or 4, 4-difluoro-l-proline, at the most immunogenic domain. Binding assays using biolayer interferometry reveal 3-fold to 10-fold affinity improvement with respect to the natural (glyco)peptides. According to X-ray crystallography and MD simulations, the fluorinated residues stabilize the antigen-antibody complex by enhancing key CH/p interactions. Interestingly, a notable improvement in detection of cancer-associated anti-MUC1 antibodies from serum of patients with prostate cancer is achieved with the non-natural antigens, which proves that these derivatives can be considered better diagnostic tools than the natural antigen for prostate cancer.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

The interdomain flexible linker of the polypeptide GalNAc transferases dictates their long-range glycosylation preferences

  • Rivas, M.D.L.
  • Lira-Navarrete, E.
  • Daniel, E.J.P.
  • Companõn, I.
  • Coelho, H.
  • Diniz, A.
  • Jiménez-Barbero, J.
  • Peregrina, J.M.
  • Clausen, H.
  • Corzana, F.
  • Marcelo, F.
  • Jiménez-Osés, G.
  • Gerken, T.A.
  • Hurtado-Guerrero, R.
The polypeptide GalNAc-transferases (GalNAc-Ts), that initiate mucin-type O-glycosylation, consist of a catalytic and a lectin domain connected by a flexible linker. In addition to recognizing polypeptide sequence, the GalNAc-Ts exhibit unique long-range N- A nd/or C-terminal prior glycosylation (GalNAc-O-Ser/Thr) preferences modulated by the lectin domain. Here we report studies on GalNAc-T4 that reveal the origins of its unique N-terminal long-range glycopeptide specificity, which is the opposite of GalNAc-T2. The GalNAc-T4 structure bound to a monoglycopeptide shows that the GalNAc-binding site of its lectin domain is rotated relative to the homologous GalNAc-T2 structure, explaining their different long-range preferences. Kinetics and molecular dynamics simulations on several GalNAc-T2 flexible linker constructs show altered remote prior glycosylation preferences, confirming that the flexible linker dictates the rotation of the lectin domain, thus modulating the GalNAc-Ts'' long-range preferences. This work for the first time provides the structural basis for the different remote prior glycosylation preferences of the GalNAc-Ts.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Structural Analysis of a GalNAc-T2 Mutant Reveals an Induced-Fit Catalytic Mechanism for GalNAc-Ts

  • de las Rivas, M.
  • Coelho, H.
  • Diniz, A.
  • Lira-Navarrete, E.
  • Compañón, I.
  • Jiménez-Barbero, J.
  • Schjoldager, K.T.
  • Bennett, E.P.
  • Vakhrushev, S.Y.
  • Clausen, H.
  • Corzana, F.
  • Marcelo, F.
  • Hurtado-Guerrero, R.
The family of polypeptide N-acetylgalactosamine (GalNAc) transferases (GalNAc-Ts) orchestrates the initiating step of mucin-type protein O-glycosylation by transfer of GalNAc moieties to serine and threonine residues in proteins. Deficiencies and dysregulation of GalNAc-T isoenzymes are related to different diseases. Recently, it has been demonstrated that an inactive GalNAc-T2 mutant (F104S), which is not located at the active site, induces low levels of high-density lipoprotein cholesterol (HDL-C) in humans. Herein, the molecular basis for F104S mutant inactivation has been deciphered. Saturation transfer difference NMR spectroscopy experiments demonstrate that the mutation induces loss of binding to peptide substrates. Analysis of the crystal structure of the F104S mutant bound to UDP-GalNAc (UDP=uridine diphosphate), combined with molecular dynamics (MD) simulations, has revealed that the flexible loop is disordered and displays larger conformational changes in the mutant enzyme than that in the wild-type (WT) enzyme. 19F NMR spectroscopy experiments reveal that the WT enzyme only reaches the active state in the presence of UDP-GalNAc, which provides compelling evidence that GalNAc-T2 adopts a UDP-GalNAc-dependent induced-fit mechanism. The F104S mutation precludes the enzyme from achieving the active conformation and concomitantly binding peptide substrates. This study provides new insights into the catalytic mechanism of the large family of GalNAc-Ts and how these enzymes orchestrate protein O-glycosylation.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Design of alpha-S-Neoglycopeptides derived from MUC1 with a flexible and solvent-exposed sugar moiety

  • Rojas-Ocáriz, Víctor
  • Compañón, Ismael
  • Aydillo, Carlos
  • Castro-López, Jorge
  • Jiménez-Barbero, Jesús
  • Hurtado-Guerrero, Ramón
  • Avenoza, Alberto
  • Zurbano, María M.
  • Peregrina, Jesús M.
  • Busto, Jesús H.
  • Corzana, Francisco
The use of vaccines based on MUC1 glycopeptides is a promising approach to treat cancer. We present herein several sulfa-Tn antigens incorporated in MUC1 sequences that possess a variable linker between the carbohydrate (GalNAc) and the peptide backbone. The main conformations of these molecules in solution have been evaluated by combining NMR experiments and molecular dynamics simulations. The linker plays a key role in the modulation of the conformation of these compounds at different levels, blocking a direct contact between the sugar moiety and the backbone, promoting a helix-like conformation for the glycosylated residue and favoring the proper presentation of the sugar unit for molecular recognition events. The feasibility of these novel compounds as mimics of MUC1 antigens has been validated by the X-ray diffraction structure of one of these unnatural derivatives complexed to an anti-MUC1 monoclonal antibody. These features, together with potential lack of immune suppression, render these unnatural glycopeptides promising candidates for designing alternative therapeutic vaccines against cancer.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Structure-Based Design of Potent Tumor-Associated Antigens: Modulation of Peptide Presentation by Single-Atom O/S or O/Se Substitutions at the Glycosidic Linkage

  • Companión, I.
  • Guerreiro, A.
  • Mangini, V.
  • Castro-López, J.
  • Escudero-Casao, M.
  • Avenoza, A.
  • Busto, J.H.
  • Castillón, S.
  • Jiménez-Barbero, J.
  • Asensio, J.L.
  • Jiménez-Osés, G.
  • Boutureira, O.
  • Peregrina, J.M.
  • Hurtado-Guerrero, R.
  • Fiammengo, R.
  • Bernardes, G.J.L.
  • Corzana, F.
GalNAc-glycopeptides derived from mucin MUC1 are an important class of tumor-associated antigens. a-O-glycosylation forces the peptide to adopt an extended conformation in solution, which is far from the structure observed in complexes with a model anti-MUC1 antibody. Herein, we propose a new strategy for designing potent antigen mimics based on modulating peptide/carbohydrate interactions by means of O â†'' S/Se replacement at the glycosidic linkage. These minimal chemical modifications bring about two key structural changes to the glycopeptide. They increase the carbohydrate-peptide distance and change the orientation and dynamics of the glycosidic linkage. As a result, the peptide acquires a preorganized and optimal structure suited for antibody binding. Accordingly, these new glycopeptides display improved binding toward a representative anti-MUC1 antibody relative to the native antigens. To prove the potential of these glycopeptides as tumor-associated MUC1 antigen mimics, the derivative bearing the S-glycosidic linkage was conjugated to gold nanoparticles and tested as an immunogenic formulation in mice without any adjuvant, which resulted in a significant humoral immune response. Importantly, the mice antisera recognize cancer cells in biopsies of breast cancer patients with high selectivity. This finding demonstrates that the antibodies elicited against the mimetic antigen indeed recognize the naturally occurring antigen in its physiological context. Clinically, the exploitation of tumor-associated antigen mimics may contribute to the development of cancer vaccines and to the improvement of cancer diagnosis based on anti-MUC1 antibodies. The methodology presented here is of general interest for applications because it may be extended to modulate the affinity of biologically relevant glycopeptides toward their receptors.